NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Union Bank of India Posts Strong 4QFY26 Results, Beats Estimates

Union Bank of India (UNBK) announced its fourth quarter (4Q) fiscal year 2026 (FY26) profit after tax (PAT) of INR53.2 billion, representing a 7% year-over-year (YoY) and 6% quarter-over-quarter (QoQ) increase. This performance was primarily driven by non-performing asset (NPA) recoveries and lower operational expenses (opex).

However, the bank's net interest income (NII) declined by 1.1% YoY and rose 0.8% QoQ to INR94.1 billion, falling short of expectations by 2%. The net interest margin (NIM) contracted to 2.64% in 4QFY26, down 12 basis points from the previous quarter, and below the Motilal Oswal Financial Services Limited (MOFSLe) estimate of 2.72%. The NIM contraction was largely attributed to the transmission of the repo rate cut.

Key Performance Indicators for 4QFY26

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Indicator4QFY26YoY ChangeQoQ Change
PAT (INR billion)53.27%6%
NII (INR billion)94.1-1.1%0.8%
NIM (%)2.64-12 bp-12 bp

In its outlook, Motilal Oswal has fine-tuned its estimates and projects a return on assets (RoA) and return on equity (RoE) of 1.1% and 13.9%, respectively, for fiscal year 2027 (FY27). The research firm expects the bank's loans to expand at a compound annual growth rate (CAGR) of 10.5% over FY26-28. Based on these projections, the research firm reiterates its Neutral rating on the stock with a target price of INR180 (1.0x September 2027 estimated adjusted book value).

Investor Takeaway

Reiterate Neutral rating on the stock with a target price of Rs 180.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.